Genelink Inc (GNLKQ)
0.00
USD |
OTCM |
Nov 13, 16:00
Genelink Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2013 | -0.3717 |
| June 30, 2013 | -0.3736 |
| March 31, 2013 | -0.3723 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.365 |
| June 30, 2012 | -0.4472 |
| March 31, 2012 | -0.6638 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | -1.957 |
| June 30, 2011 | -1.104 |
| March 31, 2011 | -1.058 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | -1.026 |
| June 30, 2010 | -1.260 |
| March 31, 2010 | -0.9345 |
| December 31, 2009 | -0.0488 |
| September 30, 2009 | -1.726 |
| June 30, 2009 | -5.337 |
| March 31, 2009 | 2.141 |
| December 31, 2008 | 1.154 |
| September 30, 2008 | -0.156 |
| June 30, 2008 | 0.6425 |
| March 31, 2008 | -2.032 |
| December 31, 2007 | 0.00 |
| September 30, 2007 | -0.1227 |
| Date | Value |
|---|---|
| June 30, 2007 | -0.0123 |
| March 31, 2007 | -0.0142 |
| December 31, 2006 | -0.3682 |
| September 30, 2006 | -0.4728 |
| June 30, 2006 | -0.5417 |
| March 31, 2006 | -0.2199 |
| December 31, 2005 | -0.0455 |
| September 30, 2005 | -0.5049 |
| June 30, 2005 | -0.2275 |
| March 31, 2005 | -0.2322 |
| December 31, 2004 | -1.073 |
| September 30, 2004 | -0.9163 |
| June 30, 2004 | -0.8895 |
| March 31, 2004 | 0.00 |
| December 31, 2003 | 0.0446 |
| September 30, 2003 | -0.1228 |
| June 30, 2003 | -0.1048 |
| March 31, 2003 | -0.1099 |
| December 31, 2002 | -0.1463 |
| September 30, 2002 | -1.309 |
| June 30, 2002 | -0.4617 |
| March 31, 2002 | -0.5502 |
| December 31, 2001 | -0.3846 |
| September 30, 2001 | -0.1415 |
| June 30, 2001 | -0.169 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.4322 |
| IGC Pharma Inc | 0.0173 |
| NovaBay Pharmaceuticals Inc | -1.128 |
| Protalix BioTherapeutics Inc | 0.7145 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.284M |
| Total Liabilities (Quarterly) | 4.488M |
| Shareholders Equity (Quarterly) | -3.203M |